Selected research
Market Structure
Global Taxifolin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Taxifolin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Taxifolin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Taxifolin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Taxifolin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Taxifolin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Taxifolin include Ametis JSC, JW Health Products, Kalenika Group, Hefei Lifeon Pharma, ROBIOS, Kingherbs Ltd, Beton Nutrition Corporation and Xi'an Sost Biotech Co.,Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Taxifolin output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Taxifolin by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Taxifolin market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Taxifolin and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Taxifolin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Taxifolin market size, projected growth trends, production technologies, key applications, and end-use industries.
Taxifolin Segment by Company
Ametis JSC
JW Health Products
Kalenika Group
Hefei Lifeon Pharma
ROBIOS
Kingherbs Ltd
Beton Nutrition Corporation
Xi'an Sost Biotech Co.,Ltd
Taxifolin Segment by Type
Below 92%
92%-98%
Above 98%
Taxifolin Segment by Application
Food and Beverages
Healthcare
Cosmetics
Agriculture
Others
Taxifolin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Taxifolin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Taxifolin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Taxifolin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Taxifolin market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Taxifolin industry.
Chapter 3: Detailed analysis of Taxifolin market competition landscape. Including Taxifolin manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Taxifolin by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Taxifolin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Below 92%
- 92%-98%
- Above 98%
Applications
- Food and Beverages
- Healthcare
- Cosmetics
- Agriculture
- Others
Companies covered
- Ametis JSC
- JW Health Products
- Kalenika Group
- Hefei Lifeon Pharma
- ROBIOS
- Kingherbs Ltd
- Beton Nutrition Corporation
- Xi'an Sost Biotech Co.,Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Taxifolin Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Taxifolin Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Taxifolin Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Taxifolin Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Taxifolin Market Dynamics
- 2.1 Taxifolin Industry Trends
- 2.2 Taxifolin Industry Drivers
- 2.3 Taxifolin Industry Opportunities and Challenges
- 2.4 Taxifolin Industry Restraints
3 Taxifolin Market by Manufacturers
- 3.1 Global Taxifolin Production Value by Manufacturers (2021-2026)
- 3.2 Global Taxifolin Production by Manufacturers (2021-2026)
- 3.3 Global Taxifolin Average Price by Manufacturers (2021-2026)
- 3.4 Global Taxifolin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Taxifolin Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Taxifolin Manufacturers, Product Type & Application
- 3.7 Global Taxifolin Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Taxifolin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Taxifolin Players Market Share by Production Value in 2025
- 3.8.3 2025 Taxifolin Tier 1, Tier 2, and Tier 3
4 Taxifolin Market by Type
- 4.1 Taxifolin Type Introduction
- 4.1.1 Below 92%
- 4.1.2 92%-98%
- 4.1.3 Above 98%
- 4.2 Global Taxifolin Production by Type
- 4.2.1 Global Taxifolin Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Taxifolin Production by Type (2021-2032)
- 4.2.3 Global Taxifolin Production Market Share by Type (2021-2032)
- 4.3 Global Taxifolin Production Value by Type
- 4.3.1 Global Taxifolin Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Taxifolin Production Value by Type (2021-2032)
- 4.3.3 Global Taxifolin Production Value Market Share by Type (2021-2032)
5 Taxifolin Market by Application
- 5.1 Taxifolin Application Introduction
- 5.1.1 Food and Beverages
- 5.1.2 Healthcare
- 5.1.3 Cosmetics
- 5.1.4 Agriculture
- 5.1.5 Others
- 5.2 Global Taxifolin Production by Application
- 5.2.1 Global Taxifolin Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Taxifolin Production by Application (2021-2032)
- 5.2.3 Global Taxifolin Production Market Share by Application (2021-2032)
- 5.3 Global Taxifolin Production Value by Application
- 5.3.1 Global Taxifolin Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Taxifolin Production Value by Application (2021-2032)
- 5.3.3 Global Taxifolin Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Ametis JSC
- 6.1.1 Ametis JSC Company Information
- 6.1.2 Ametis JSC Business Overview
- 6.1.3 Ametis JSC Taxifolin Production, Value and Gross Margin (2021-2026)
- 6.1.4 Ametis JSC Taxifolin Product Portfolio
- 6.1.5 Ametis JSC Recent Developments
- 6.2 JW Health Products
- 6.2.1 JW Health Products Company Information
- 6.2.2 JW Health Products Business Overview
- 6.2.3 JW Health Products Taxifolin Production, Value and Gross Margin (2021-2026)
- 6.2.4 JW Health Products Taxifolin Product Portfolio
- 6.2.5 JW Health Products Recent Developments
- 6.3 Kalenika Group
- 6.3.1 Kalenika Group Company Information
- 6.3.2 Kalenika Group Business Overview
- 6.3.3 Kalenika Group Taxifolin Production, Value and Gross Margin (2021-2026)
- 6.3.4 Kalenika Group Taxifolin Product Portfolio
- 6.3.5 Kalenika Group Recent Developments
- 6.4 Hefei Lifeon Pharma
- 6.4.1 Hefei Lifeon Pharma Company Information
- 6.4.2 Hefei Lifeon Pharma Business Overview
- 6.4.3 Hefei Lifeon Pharma Taxifolin Production, Value and Gross Margin (2021-2026)
- 6.4.4 Hefei Lifeon Pharma Taxifolin Product Portfolio
- 6.4.5 Hefei Lifeon Pharma Recent Developments
- 6.5 ROBIOS
- 6.5.1 ROBIOS Company Information
- 6.5.2 ROBIOS Business Overview
- 6.5.3 ROBIOS Taxifolin Production, Value and Gross Margin (2021-2026)
- 6.5.4 ROBIOS Taxifolin Product Portfolio
- 6.5.5 ROBIOS Recent Developments
- 6.6 Kingherbs Ltd
- 6.6.1 Kingherbs Ltd Company Information
- 6.6.2 Kingherbs Ltd Business Overview
- 6.6.3 Kingherbs Ltd Taxifolin Production, Value and Gross Margin (2021-2026)
- 6.6.4 Kingherbs Ltd Taxifolin Product Portfolio
- 6.6.5 Kingherbs Ltd Recent Developments
- 6.7 Beton Nutrition Corporation
- 6.7.1 Beton Nutrition Corporation Company Information
- 6.7.2 Beton Nutrition Corporation Business Overview
- 6.7.3 Beton Nutrition Corporation Taxifolin Production, Value and Gross Margin (2021-2026)
- 6.7.4 Beton Nutrition Corporation Taxifolin Product Portfolio
- 6.7.5 Beton Nutrition Corporation Recent Developments
- 6.8 Xi'an Sost Biotech Co.,Ltd
- 6.8.1 Xi'an Sost Biotech Co.,Ltd Company Information
- 6.8.2 Xi'an Sost Biotech Co.,Ltd Business Overview
- 6.8.3 Xi'an Sost Biotech Co.,Ltd Taxifolin Production, Value and Gross Margin (2021-2026)
- 6.8.4 Xi'an Sost Biotech Co.,Ltd Taxifolin Product Portfolio
- 6.8.5 Xi'an Sost Biotech Co.,Ltd Recent Developments
7 Global Taxifolin Production by Region
- 7.1 Global Taxifolin Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Taxifolin Production by Region (2021-2032)
- 7.2.1 Global Taxifolin Production by Region (2021-2026)
- 7.2.2 Global Taxifolin Production Forecast by Region (2027-2032)
- 7.3 Global Taxifolin Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Taxifolin Production Value by Region (2021-2032)
- 7.4.1 Global Taxifolin Production Value by Region (2021-2026)
- 7.4.2 Global Taxifolin Production Value by Region (2027-2032)
- 7.5 Global Taxifolin Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Taxifolin Production Value (2021-2032)
- 7.6.2 Europe Taxifolin Production Value (2021-2032)
- 7.6.3 Asia-Pacific Taxifolin Production Value (2021-2032)
- 7.6.4 South America Taxifolin Production Value (2021-2032)
- 7.6.5 Middle East & Africa Taxifolin Production Value (2021-2032)
8 Global Taxifolin Consumption by Region
- 8.1 Global Taxifolin Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Taxifolin Consumption by Region (2021-2032)
- 8.2.1 Global Taxifolin Consumption by Region (2021-2026)
- 8.2.2 Global Taxifolin Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Taxifolin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Taxifolin Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Taxifolin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Taxifolin Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Taxifolin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Taxifolin Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Taxifolin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Taxifolin Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Taxifolin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Taxifolin Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Taxifolin Value Chain Analysis
- 9.1.1 Taxifolin Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Taxifolin Production Mode & Process
- 9.2 Taxifolin Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Taxifolin Distributors
- 9.2.3 Taxifolin Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst